.jpg)
bioniq, the leading Health and wellness AI platform delivering the world’s most personalized wellness solutions, today announces the appointment of its new COO, Co-Founder, and Board Director, Ahmad El-Dardiry. This is an important milestone in the company’s mission to improve global health through its offering of tailor-made health and wellness services.
Most recently, El-Dardiry, served as President and COO of Tread, a SaaS company, where he reshaped product, engineering and GTM - driving a strong product market fit and 4x business growth under his leadership. Having spent nearly 20 years at Intel, as a General Manager, El-Dardiry is highly accomplished in building and leading diverse, global teams, with significant experience across technology, operations, sales and marketing. Following his successful career at Intel, El-Dardiry served as Chief Operating Officer and General Manager at Transfix, one of Forbes’ Next Billion Dollar StartUps.
As bioniq’s newly appointed COO, El-Dardiry will lead all growth markets, operations and global marketing. Currently operating across six countries in EMEA, bioniq plans to expand into 10 new markets by the end of 2023 under his leadership. El-Dardiry will immediately be driving the strategy and operations for bioniq North America expansion and setting up a New York office for its US operations
With an impressive career spanning early stage start-ups to scaling global businesses, El-Dardiry adds: “I am honored to be joining the bioniq team to make personalized health and wellness accessible and actionable, which has been a lifelong passion for me. Our unmatched database of over 3 million biochemical markers, coupled with our patented bioniq algorithm, positions us to deliver data-driven precision health and wellness solutions with a superior experience to members around the world. We are excited to scale our platform for global impact ”
bioniq CEO, Vadim Fedotov says of the appointment: “We are extremely excited to have Ahmad join us and bring a wealth of strong expertise and experience in strategy, operation and scaling companies. Our worldwide health platform is a glimpse into the future of personalized health - in the form of tailor-made wellness solutions driven by data and innovation - and together, it is our goal to support, motivate and educate people across the world to lead as fulfilled and healthy lives as possible.”
Boasting one of the largest researched databases in the world, bioniq partners with leading institutions such as London Global Practice, King’s College Hospital and Lanserhof. The company is backed by some of the leading global VC funds including HV Capital, Rocket Internet, Unbound Venture, Porsche Ventures and TQ Ventures.
bioniq has also recently acquired VAHA, Europe’s largest and leading connected fitness offering. With 35 design patents, VAHA’s AI driven state-of-the-art home fitness technology accesses millions of workout-related data points, providing bioniq members with personalized home training and biomechanical analysis for further insight into their body’s physical capabilities.
For more information on the future of bespoke health solutions, visit www.bioniq.com
PRESS ENQUIRIES: pr@bioniq.com
About bioniq
bioniq, founded in 2019 with headquarters in London, is the ultimate health support system. Research-based, clinically proven and driven by world-leading data, bioniq’s mission is to make health accessible and actionable. Currently, the company operates in the UK, UAE, Germany, Austria, Switzerland and the Netherlands, and is proud to have been featured as the ‘Biggest Wellbeing Trend”’ according to The Evening Standard, Women’s Health, The Telegraph, GQ and Elle.
.jpg)
